Gluten intolerance
Analysis of selected HLA variants provides information about genetic predisposition relevant to the assessment of coeliac disease.
Explore this testSelected tests for genetic susceptibility to disease. Explore the markers examined and the information provided by each result, and discuss test selection with our team.
Analysis of selected HLA variants provides information about genetic predisposition relevant to the assessment of coeliac disease.
Explore this test
Testing selected ALDOB variants provides information relevant to the assessment of hereditary fructose intolerance.
Explore this test
Testing selected HLA-DRA variants provides genetic information considered in research on susceptibility to peanut allergy.
Explore this test
Analysis of selected KIAA0319 and DCDC2 variants provides information considered in research on susceptibility to dyslexia.
Explore this test
Analysis of selected APOE and TREM2 variants provides information considered in the assessment of susceptibility to Alzheimer's disease.
Explore this test
Testing selected SNCA variants provides genetic information relevant to the assessment of susceptibility to Parkinson's disease.
Explore this test
Testing selected CDKAL1 variants provides information about genetic markers associated with susceptibility to type 2 diabetes.
Explore this test
Analysis of selected FTO variants provides information about genetic factors associated with body weight.
Explore this test
Testing selected ACE and NOS3 variants provides information about markers considered in blood pressure regulation. It concerns susceptibility rather than a current blood pressure r...
Explore this test
Testing selected LPA and AGT variants provides information about genetic factors associated with lipid metabolism and cardiovascular regulation.
Explore this test
Testing selected PRSS1 and SPINK1 variants provides information relevant to inherited pancreatic conditions, particularly those associated with pancreatitis.
Explore this test
Testing selected BRCA1 and BRCA2 variants provides information that may be relevant to inherited predisposition to breast and ovarian cancer.
Explore this test
Analysis of selected variants associated with inherited susceptibility to colorectal cancer provides genetic information within the specified test scope.
Explore this test
Testing selected HOXB13 and CHEK2 variants provides information considered in the assessment of inherited susceptibility to prostate cancer.
Explore this test
Testing selected MC1R and CDKN2A variants provides information about pigmentation and selected inherited factors associated with melanoma susceptibility.
Explore this test
Testing selected CHRNA3 and CDKN1A variants provides information about markers described in studies of susceptibility to lung cancer.
Explore this test
Testing HLA markers associated with psoriasis provides genetic information considered in the assessment of susceptibility to this condition.
Explore this test
This test identifies a specified F5 variant associated with an inherited tendency to venous thromboembolism.
Explore this test
Testing the prothrombin gene F2 identifies a specified variant considered in the assessment of inherited susceptibility to venous thrombosis.
Explore this test
FVR2 testing concerns a selected variant or R2 haplotype within F5. It provides genotype information distinct from Factor V Leiden testing.
Explore this test
PAI-1 testing provides information about a selected genetic polymorphism associated with regulation of fibrinolysis, the process of dissolving a blood clot.
Explore this test
This test examines a human genetic variant described in population studies of COVID-19 severity. It provides genotype information rather than detecting the virus.
Explore this test
Testing selected FLG variants provides information about changes in the filaggrin gene, which is important for the epidermal barrier.
Explore this test